Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Howard Lee Weiner, M.D.

Co-Author

This page shows the publications co-authored by Howard Weiner and Francisco Quintana.
Connection Strength

7.437
  1. Antigen microarrays identify CNS-produced autoantibodies in RRMS. Neurology. 2012 Feb 21; 78(8):532-9.
    View in: PubMed
    Score: 0.522
  2. An endogenous aryl hydrocarbon receptor ligand acts on dendritic cells and T cells to suppress experimental autoimmune encephalomyelitis. Proc Natl Acad Sci U S A. 2010 Nov 30; 107(48):20768-73.
    View in: PubMed
    Score: 0.481
  3. Adaptive autoimmunity and Foxp3-based immunoregulation in zebrafish. PLoS One. 2010 Mar 05; 5(3):e9478.
    View in: PubMed
    Score: 0.459
  4. Environmental control of Th17 differentiation. Eur J Immunol. 2009 Mar; 39(3):655-7.
    View in: PubMed
    Score: 0.428
  5. Antigen microarrays identify unique serum autoantibody signatures in clinical and pathologic subtypes of multiple sclerosis. Proc Natl Acad Sci U S A. 2008 Dec 02; 105(48):18889-94.
    View in: PubMed
    Score: 0.420
  6. Systems biology approaches for the study of multiple sclerosis. J Cell Mol Med. 2008 Aug; 12(4):1087-93.
    View in: PubMed
    Score: 0.406
  7. Control of T(reg) and T(H)17 cell differentiation by the aryl hydrocarbon receptor. Nature. 2008 May 01; 453(7191):65-71.
    View in: PubMed
    Score: 0.401
  8. Understanding natural and pathological autoimmunity. J Neuroimmunol. 2006 May; 174(1-2):1-2.
    View in: PubMed
    Score: 0.348
  9. Serum antibodies to phosphatidylcholine in MS. Neurol Neuroimmunol Neuroinflamm. 2020 07; 7(4).
    View in: PubMed
    Score: 0.234
  10. Author Correction: Control of tumor-associated macrophages and T cells in glioblastoma via AHR and CD39. Nat Neurosci. 2019 Sep; 22(9):1533.
    View in: PubMed
    Score: 0.221
  11. Control of tumor-associated macrophages and T cells in glioblastoma via AHR and CD39. Nat Neurosci. 2019 05; 22(5):729-740.
    View in: PubMed
    Score: 0.215
  12. Dynamic regulation of serum aryl hydrocarbon receptor agonists in MS. Neurol Neuroimmunol Neuroinflamm. 2017 Jul; 4(4):e359.
    View in: PubMed
    Score: 0.190
  13. AHR Activation Is Protective against Colitis Driven by T Cells in Humanized Mice. Cell Rep. 2016 10 25; 17(5):1318-1329.
    View in: PubMed
    Score: 0.182
  14. Mucosal administration of CD3-specific monoclonal antibody inhibits diabetes in NOD mice and in a preclinical mouse model transgenic for the CD3 epsilon chain. J Autoimmun. 2017 01; 76:115-122.
    View in: PubMed
    Score: 0.181
  15. Alterations of the human gut microbiome in multiple sclerosis. Nat Commun. 2016 06 28; 7:12015.
    View in: PubMed
    Score: 0.178
  16. IL-10-dependent Tr1 cells attenuate astrocyte activation and ameliorate chronic central nervous system inflammation. Brain. 2016 07; 139(Pt 7):1939-57.
    View in: PubMed
    Score: 0.177
  17. Serum lipid antibodies are associated with cerebral tissue damage in multiple sclerosis. Neurol Neuroimmunol Neuroinflamm. 2016 Apr; 3(2):e200.
    View in: PubMed
    Score: 0.173
  18. Epitope spreading as an early pathogenic event in pediatric multiple sclerosis. Neurology. 2014 Dec 09; 83(24):2219-26.
    View in: PubMed
    Score: 0.159
  19. Regulation of astrocyte activation by glycolipids drives chronic CNS inflammation. Nat Med. 2014 Oct; 20(10):1147-56.
    View in: PubMed
    Score: 0.157
  20. Circulating microRNAs as biomarkers for disease staging in multiple sclerosis. Ann Neurol. 2013 Jun; 73(6):729-40.
    View in: PubMed
    Score: 0.145
  21. The innate immune system in demyelinating disease. Immunol Rev. 2012 Jul; 248(1):170-87.
    View in: PubMed
    Score: 0.135
  22. Activated human CD4+CD45RO+ memory T-cells indirectly inhibit NLRP3 inflammasome activation through downregulation of P2X7R signalling. PLoS One. 2012; 7(6):e39576.
    View in: PubMed
    Score: 0.135
  23. Nanoparticle-mediated codelivery of myelin antigen and a tolerogenic small molecule suppresses experimental autoimmune encephalomyelitis. Proc Natl Acad Sci U S A. 2012 Jul 10; 109(28):11270-5.
    View in: PubMed
    Score: 0.135
  24. Lipids and lipid-reactive antibodies as biomarkers for multiple sclerosis. J Neuroimmunol. 2012 Jul 15; 248(1-2):53-7.
    View in: PubMed
    Score: 0.133
  25. In vivo induction of Tr1 cells via mucosal dendritic cells and AHR signaling. PLoS One. 2011; 6(8):e23618.
    View in: PubMed
    Score: 0.127
  26. Oral tolerance. Immunol Rev. 2011 May; 241(1):241-59.
    View in: PubMed
    Score: 0.124
  27. Activation of the aryl hydrocarbon receptor induces human type 1 regulatory T cell-like and Foxp3(+) regulatory T cells. Nat Immunol. 2010 Sep; 11(9):846-53.
    View in: PubMed
    Score: 0.118
  28. Cutting edge: human latency-associated peptide+ T cells: a novel regulatory T cell subset. J Immunol. 2010 May 01; 184(9):4620-4.
    View in: PubMed
    Score: 0.115
  29. Oral administration of OKT3 monoclonal antibody to human subjects induces a dose-dependent immunologic effect in T cells and dendritic cells. J Clin Immunol. 2010 Jan; 30(1):167-77.
    View in: PubMed
    Score: 0.111
  30. Toll-like receptor 2 and poly(ADP-ribose) polymerase 1 promote central nervous system neuroinflammation in progressive EAE. Nat Immunol. 2009 Sep; 10(9):958-64.
    View in: PubMed
    Score: 0.110
  31. Nasal anti-CD3 antibody ameliorates lupus by inducing an IL-10-secreting CD4+ CD25- LAP+ regulatory T cell and is associated with down-regulation of IL-17+ CD4+ ICOS+ CXCR5+ follicular helper T cells. J Immunol. 2008 Nov 01; 181(9):6038-50.
    View in: PubMed
    Score: 0.105
  32. Reversal of axonal loss and disability in a mouse model of progressive multiple sclerosis. J Clin Invest. 2008 Apr; 118(4):1532-43.
    View in: PubMed
    Score: 0.100
  33. Checkpoint Receptor TIGIT Expressed on Tim-1+ B Cells Regulates Tissue Inflammation. Cell Rep. 2020 07 14; 32(2):107892.
    View in: PubMed
    Score: 0.059
  34. MRI phenotypes in MS: Longitudinal changes and miRNA signatures. Neurol Neuroimmunol Neuroinflamm. 2019 03; 6(2):e530.
    View in: PubMed
    Score: 0.053
  35. Sample size requirements for one-year treatment effects using deep gray matter volume from 3T MRI in progressive forms of multiple sclerosis. Int J Neurosci. 2017 Nov; 127(11):971-980.
    View in: PubMed
    Score: 0.046
  36. Evaluation of circulating osteopontin levels in an unselected cohort of patients with multiple sclerosis: relevance for biomarker development. Mult Scler. 2014 Apr; 20(4):438-44.
    View in: PubMed
    Score: 0.037
  37. Gut-tropic T cells that express integrin a4ß7 and CCR9 are required for induction of oral immune tolerance in mice. Gastroenterology. 2011 Dec; 141(6):2109-18.
    View in: PubMed
    Score: 0.032
  38. The aryl hydrocarbon receptor interacts with c-Maf to promote the differentiation of type 1 regulatory T cells induced by IL-27. Nat Immunol. 2010 Sep; 11(9):854-61.
    View in: PubMed
    Score: 0.030
  39. T and B cell hyperactivity and autoimmunity associated with niche-specific defects in apoptotic body clearance in TIM-4-deficient mice. Proc Natl Acad Sci U S A. 2010 May 11; 107(19):8706-11.
    View in: PubMed
    Score: 0.029
  40. Natalizumab treatment is associated with peripheral sequestration of proinflammatory T cells. Neurology. 2009 Jun 02; 72(22):1922-30.
    View in: PubMed
    Score: 0.027
Connection Strength
The connection strength for co-authors is the sum of the scores for each of their shared publications.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.